🇨🇦 Use of bromfenac 0.09% to reduce intravitreal injection pain in Canada

Use of bromfenac 0.09% to reduce intravitreal injection pain (Use of bromfenac 0.09% to reduce intravitreal injection pain) regulatory status in Canada.

Marketing authorisation

Use of bromfenac 0.09% to reduce intravitreal injection pain in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Use of bromfenac 0.09% to reduce intravitreal injection pain approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Use of bromfenac 0.09% to reduce intravitreal injection pain in Canada?

Wills Eye is the originator. The local marketing authorisation holder may differ — check the official source linked above.